Yoichi Arai Selected Research

Messenger RNA (mRNA)

1/2017	The Piezo Actuator-Driven Pulsed Water Jet System for Minimizing Renal Damage after Off-Clamp Laparoscopic Partial Nephrectomy.
5/2015	Pre-B Lymphocyte Protein 3 (VPREB3) Expression in the Adrenal Cortex: Precedent for non-Immunological Roles in Normal and Neoplastic Human Tissues.
5/2013	Cyclin D1 (CCND1) expression is involved in estrogen receptor beta (ERβ) in human prostate cancer.
7/2008	Expression of adrenomedullin 2/intermedin in human adrenal tumors and attached non-neoplastic adrenal tissues.
4/2006	N-acetylglucosaminyltransferase V and beta1-6 branching N-linked oligosaccharides are associated with good prognosis of patients with bladder cancer.
3/2006	Plasma membrane-associated sialidase is up-regulated in renal cell carcinoma and promotes interleukin-6-induced apoptosis suppression and cell motility.
11/2002	Clinical significance of ST3Gal IV expression in human renal cell carcinoma.
7/2002	Upregulated expression of transforming growth factor-beta, type IV collagen, and plasminogen activator inhibitor-1 mRNA are decreased after release of unilateral ureteral obstruction.
7/2002	Ganglioside G(M3) overexpression induces apoptosis and reduces malignant potential in murine bladder cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoichi Arai Research Topics

Disease

106	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 01/2002
77	Neoplasms (Cancer) 01/2021 - 06/2002
24	Renal Cell Carcinoma (Grawitz Tumor) 03/2022 - 11/2002
22	Neoplasm Metastasis (Metastasis) 02/2019 - 10/2002
21	Carcinoma (Carcinomatosis) 01/2018 - 07/2002
20	Urinary Bladder Neoplasms (Bladder Cancer) 01/2020 - 07/2002
12	Hyperaldosteronism (Conn Syndrome) 01/2019 - 07/2005
11	Adenoma (Adenomas) 02/2016 - 07/2005
9	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2019 - 04/2003
8	Testicular Neoplasms (Testicular Cancer) 10/2021 - 10/2002
7	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2018 - 07/2003
7	Erectile Dysfunction 10/2016 - 06/2002
5	Lymphatic Metastasis 01/2019 - 01/2004
5	Infections 01/2018 - 10/2004
5	Urinary Incontinence 01/2018 - 07/2005
5	Hemorrhage 10/2016 - 04/2011
5	Sneezing 06/2015 - 02/2007
5	Stress Urinary Incontinence 06/2015 - 02/2007
5	Testicular Germ Cell Tumor 08/2014 - 06/2004
4	Margins of Excision 09/2021 - 02/2004
4	Urologic Neoplasms (Urological Cancer) 05/2021 - 09/2005
4	Hydronephrosis 03/2014 - 07/2006
4	Carcinogenesis 01/2008 - 11/2002
3	Diabetes Mellitus 08/2021 - 10/2013
3	Hypertension (High Blood Pressure) 08/2021 - 07/2005
3	Ischemia 01/2019 - 06/2004
3	Lower Urinary Tract Symptoms 01/2019 - 10/2004
3	Inguinal Hernia (Direct Inguinal Hernia) 01/2016 - 02/2004
3	Pain (Aches) 01/2016 - 12/2004
3	Adrenocortical Carcinoma 06/2015 - 05/2008
3	Seminoma 05/2005 - 09/2003
2	Dyslipidemias (Dyslipidemia) 08/2021 - 01/2018
2	Pathologic Constriction (Stenosis) 01/2021 - 07/2006
2	Hyperplasia 01/2019 - 05/2015
2	Hypothermia 01/2019 - 04/2011

Drug/Important Bio-Agent (IBA)

29	Prostate-Specific Antigen (Semenogelase)IBA 12/2019 - 01/2002
24	AndrogensIBA 01/2022 - 11/2002
13	Hormones (Hormone)IBA 01/2022 - 10/2002
12	Cisplatin (Platino)FDA LinkGeneric 10/2021 - 06/2002
12	AldosteroneIBA 01/2019 - 07/2005
10	Docetaxel (Taxotere)FDA Link 02/2019 - 04/2003
9	Gonadotropin-Releasing Hormone (GnRH)FDA Link 01/2021 - 04/2003
9	Messenger RNA (mRNA)IBA 01/2017 - 07/2002
8	Gemcitabine FDA Link 01/2020 - 04/2003
8	Biomarkers (Surrogate Marker)IBA 01/2019 - 08/2008
7	EnzymesIBA 01/2019 - 07/2002
7	Monoclonal AntibodiesIBA 01/2018 - 05/2005
6	Biological ProductsIBA 12/2017 - 10/2002
6	GangliosidesIBA 01/2017 - 07/2002
6	LigandsIBA 10/2012 - 12/2003
5	Androgen Receptors (Androgen Receptor)IBA 01/2021 - 01/2009
5	Proteins (Proteins, Gene)FDA Link 01/2019 - 05/2004
5	Pharmaceutical PreparationsIBA 01/2018 - 03/2008
5	Polysaccharides (Glycans)IBA 04/2017 - 10/2005
5	Forssman glycolipid (GL-5)IBA 01/2017 - 07/2003
5	CarbohydratesIBA 04/2006 - 10/2002
4	Therapeutic UsesIBA 01/2021 - 09/2006
4	Estrogens (Estrogen)FDA Link 01/2020 - 06/2006
4	Oxidoreductases (Dehydrogenase)IBA 09/2019 - 12/2014
4	Phosphodiesterase 5 InhibitorsIBA 01/2019 - 06/2011
4	bicalutamide (Casodex)FDA LinkGeneric 06/2018 - 01/2004
4	pirarubicinIBA 01/2018 - 07/2005
4	Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric 01/2018 - 05/2007
4	Tumor Biomarkers (Tumor Markers)IBA 12/2015 - 05/2004
4	Carboplatin (JM8)FDA LinkGeneric 11/2014 - 04/2003
4	OligosaccharidesIBA 01/2008 - 10/2002
3	Sunitinib (Sutent)FDA Link 01/2021 - 02/2017
3	SteroidsIBA 01/2019 - 01/2009
3	Interleukin-6 (Interleukin 6)IBA 10/2016 - 03/2006
3	HaptoglobinsIBA 10/2012 - 01/2008
3	CalreticulinIBA 05/2009 - 05/2004
3	Sialyl Lewis X AntigenIBA 01/2008 - 10/2002
3	Peptides (Polypeptides)IBA 01/2008 - 10/2003
3	ParaffinIBA 04/2006 - 01/2004
2	Small Interfering RNA (siRNA)IBA 01/2020 - 06/2004
2	Hemoglobins (Hemoglobin)IBA 09/2019 - 02/2019
2	cabazitaxel FDA Link 02/2019 - 10/2015
2	Steroid Receptors (Steroid Receptor)IBA 01/2019 - 01/2009
2	ReninIBA 01/2019 - 07/2005
2	Tadalafil (Cialis)FDA Link 01/2019 - 12/2014
2	Type 5 Cyclic Nucleotide PhosphodiesterasesIBA 01/2019 - 06/2011
2	SU 12662IBA 10/2018 - 02/2017

Therapy/Procedure

55	Prostatectomy (Retropubic Prostatectomy) 09/2021 - 04/2003
51	Therapeutics 03/2022 - 07/2002
20	Drug Therapy (Chemotherapy) 10/2021 - 06/2002
14	Castration 01/2021 - 01/2012
13	Nephrectomy 03/2022 - 01/2004
12	Radiotherapy 08/2021 - 02/2003
10	Aftercare (After-Treatment) 10/2021 - 02/2003
10	Lymph Node Excision (Lymph Node Dissection) 10/2017 - 10/2002
9	Orchiectomy (Orchidectomy) 05/2017 - 05/2003
8	Adrenalectomy 01/2019 - 07/2005
8	Nephroureterectomy 01/2018 - 12/2002
7	Cystectomy 05/2021 - 06/2002
7	Catheters 01/2017 - 08/2006
6	Intravesical Administration 01/2018 - 07/2005
4	Neoadjuvant Therapy 01/2020 - 02/2004
4	Operative Time 12/2013 - 06/2004
3	Transurethral Resection of Prostate (TURP) 08/2021 - 04/2003
3	Ureterostomy 01/2021 - 07/2006